Customize your JAMA Network experience by selecting one or more topics from the list below.
Each year, in the early spring, JAMA Ophthalmology leadership pauses momentarily to review substantial changes over the past year and to thank our editorial board, the Advisory Committee, other journal staff, peer reviewers, and authors for contributing to the journal’s mission, “To be the indispensable source of ophthalmic knowledge by promptly publishing innovative, clinically relevant research through consistent and authoritative peer review and, thereby, to be the first choice of authors for their important manuscripts.” We also look back over the year and reflect on how we are doing.
For the first time in the journal’s 150-year history, more than 50% of the editorial board members were women in 2019. Why is it important to be aware of this demographic? In 2017, the American Academy of Ophthalmology reported that 24% of its members and fellows actively practicing in the United States were women, as were half of the ophthalmology residents.1 Nevertheless, the Editors in Chief of the top 10 ophthalmology journals, based on impact factor in 2019, were all men. The percentage of women on these editorial boards ranged from 11% to 53%. Four of these 10 journals mostly publish review articles rather than original investigations, and women comprised 11%, 32%, 30%, and 23% of their editorial boards in 2019. For the 6 other ophthalmology journals, women comprised 37%, 53% (JAMA Ophthalmology), 18%, 19%, 42%, and 15% of their editorial boards in 2019. While the editorial boards of ophthalmology journals have appropriate expertise, recognizing the sex imbalance allows for the consideration of possible unconscious bias, since editorial board members have a substantial role influencing what submissions get published and who writes opinion pieces, such as Invited Commentaries or Editorials. The editors and other editorial board members at JAMA Ophthalmology remain committed to sex parity for the journal.
Other measures of the journal can be seen in the Table2-4 and the statistics found in similar tables provided from previous years. For example, the number of research manuscripts received increased by 3.3% from 2018. Since the total number of publications remained approximately the same, invariably, the acceptance rate decreased. The acceptance rate of research submissions in 2019 was 10% compared with 13% in 2018. The global reach of the journal continues to grow, with more than 34 000 recipients of the electronic table of contents each week compared with 29 587 in 2018, an increase of more than 15%; there were more than 3.1 million full-text/PDF downloads in 2019 compared with more than 2.9 million in 2018, representing a 7% increase around the world.
The journal’s success remains dependent on providing articles that may have a great effect on clinical practice, such as randomized clinical trials, and depends on peer reviewers5 whose experience and expertise helps to bring out the best in each investigation that the journal publishes. On behalf of the journal’s editorial board and Advisory Committee, I thank our peer reviewers for their invaluable contributions to the journal, along with the authors of JAMA Ophthalmology publications, who share their scientific investigations in this way. We look back on 2019, the 150th Anniversary of JAMA Ophthalmology, with pride but look forward to even more novel, clinically relevant articles in the years to come.
Corresponding Author: Neil M. Bressler, MD, Wilmer Eye Institute, Johns Hopkins University School of Medicine, Johns Hopkins Hospital, 600 N Wolfe St, Maumenee 7th Floor, Baltimore, MD 21287 (firstname.lastname@example.org).
Published Online: March 26, 2020. doi:10.1001/jamaophthalmol.2020.0480
Conflict of Interest Disclosures: None reported.
Identify all potential conflicts of interest that might be relevant to your comment.
Conflicts of interest comprise financial interests, activities, and relationships within the past 3 years including but not limited to employment, affiliation, grants or funding, consultancies, honoraria or payment, speaker's bureaus, stock ownership or options, expert testimony, royalties, donation of medical equipment, or patents planned, pending, or issued.
Err on the side of full disclosure.
If you have no conflicts of interest, check "No potential conflicts of interest" in the box below. The information will be posted with your response.
Not all submitted comments are published. Please see our commenting policy for details.
Bressler NM. JAMA Ophthalmology—The Year in Review, 2019: Striving for Sex Parity in Leadership and Excellence in Publications. JAMA Ophthalmol. Published online March 26, 2020. doi:10.1001/jamaophthalmol.2020.0480
Coronavirus Resource Center
Create a personal account or sign in to: